Your browser doesn't support javascript.
loading
Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line.
Abedi Gaballu, Fereydoon; Abbaspour-Ravasjani, Soheil; Mansoori, Behzad; Yekta, Reza; Hamishehkar, Hamed; Mohammadi, Ali; Dehghan, Gholamreza; Shokouhi, Behrooz; Ghahremani Dehbokri, Shaho; Baradaran, Behzad.
Affiliation
  • Abedi Gaballu F; Immounology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Abbaspour-Ravasjani S; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mansoori B; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Yekta R; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hamishehkar H; Immounology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mohammadi A; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Dehghan G; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Shokouhi B; Immounology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghahremani Dehbokri S; Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Baradaran B; Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran.
Iran J Pharm Res ; 18(3): 1168-1179, 2019.
Article in En | MEDLINE | ID: mdl-32641930

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Iran J Pharm Res Year: 2019 Document type: Article Affiliation country: Iran Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Iran J Pharm Res Year: 2019 Document type: Article Affiliation country: Iran Country of publication: Netherlands